Results for tag: "Avascular Necrosis Drug"

The Avascular Necrosis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Avascular Necrosis (AVN) is a condition in which the bone tissue dies due to a lack of blood supply. It is most commonly caused by trauma, alcohol abuse, or steroid use. Treatment for AVN includes medications, physical therapy, and surgery. Medications used to treat AVN include bisphosphonates, calcitonin, and prostaglandin analogs. The Musculoskeletal Disorders Drugs market is a rapidly growing market, driven by the increasing prevalence of musculoskeletal disorders, such as osteoarthritis, rheumatoid arthritis, and AVN. The market is expected to grow due to the increasing demand for effective treatments and the development of new drugs. Some companies in the Avascular Necrosis Drug market include Pfizer, Merck, Novartis, and Eli Lilly. Show Less Read more